Serena T Wong MD
Breast Cancer
Vice Chair, Regional Care Network, Memorial Sloan Kettering Cancer Center
480 Red Hill RoadMiddletown, NJ 07748
Fax+1 201-691-6685
Overview of Dr. Wong
Dr. Serena Wong is an oncologist in Middletown, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Hackensack Meridian Health Riverview Medical Center, and Memorial Sloan Kettering Monmouth. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 25 years. Dr. Wong accepts several types of health insurance, listed below. She is one of 523 doctors at Memorial Sloan Kettering Cancer Center and one of 46 doctors at Hackensack Meridian Health Riverview Medical Center who specialize in Oncology. She has 7 publications and over 100 citings.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2005 - 2008
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2001 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2004 - 2028
NJ State Medical License 2004 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2013-2016
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013-2016
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013-2016
Publications & Presentations
PubMed
- 6 citationsCardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy.Anthony F Yu, Chau T Dang, Chaya S Moskowitz, Akriti Mishra Meza, Patricia DeFusco
JACC. Cardiooncology. 2025-06-01 - 12 citationsAdjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.Elaine M Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S Ross
Breast Cancer Research and Treatment. 2022-10-01 - HDAC inhibitor research: still in its infancy.Serena T. Wong, Mark N. Stein
Oncology. 2010-02-01
Press Mentions
Experts Urge Early Detection for Persons at High Risk for Breast CancerOctober 3rd, 2024- Missed a Mammogram During COVID-19? Heres Why You Need to Reschedule as Soon as PossibleOctober 6th, 2021
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
GHI PPO
Great West PPO
HIP of New York - Select PPOHorizon BCBS Direct Access
Horizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
